CM
TGTX icon

Caption Management’s TG Therapeutics TGTX Stock Holding History

Caption Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$997K Sell
30,000
-129,700
-81% -$3.87M 0.01% 1025
2025
Q4 		$4.76M Buy
159,700
+1,100
+0.7% +$35.9K 0.03% 536
2025
Q3 		$5.73M Buy
+158,600
New +$5.22M 0.04% 440
2025
Q2 		– Sell
-90,700
Closed -$3.58M – 1889
2025
Q1 		$3.58M Sell
90,700
-65,000
-42% -$2.19M 0.03% 501
2024
Q4 		$4.69M Buy
155,700
+125,700
+419% +$3.61M 0.04% 388
2024
Q3 		$702K Buy
+30,000
New +$655K 0.01% 867
2024
Q2 		– Sell
-15,000
Closed -$228K – 1495
2024
Q1 		$228K Sell
15,000
-55,000
-79% -$876K ﹤0.01% 990
2023
Q4 		$1.2M Sell
70,000
-57,000
-45% -$662K 0.02% 765
2023
Q3 		$1.06M Buy
127,000
+55,800
+78% +$778K 0.02% 760
2023
Q2 		$1.77M Buy
71,200
+56,200
+375% +$1.45M 0.03% 528
2023
Q1 		$226K Sell
15,000
-25,000
-63% -$380K ﹤0.01% 911
2022
Q4 		$473K Sell
40,000
-45,800
-53% -$332K 0.01% 937
2022
Q3 		$507K Buy
85,800
+40,000
+87% +$262K 0.01% 1074
2022
Q2 		$195K Buy
45,800
+45,000
+5,625% +$281K ﹤0.01% 1241
2022
Q1 		$8K Sell
800
-639,100
-100% -$7.4M ﹤0.01% 1391
2021
Q4 		$12.2M Buy
639,900
+582,400
+1,013% +$15.1M 0.14% 189
2021
Q3 		$1.91M Buy
57,500
+32,500
+130% +$1.01M 0.02% 776
2021
Q2 		$969K Buy
+25,000
New +$982K 0.01% 905
2018
Q4 		– Sell
-193,300
Closed -$1.08M – 619
2018
Q3 		$1.08M Buy
+193,300
New +$2.21M 0.06% 334

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Caption Management's TGTX Position: Q4 2025 in Review

Caption Management sold out of TG Therapeutics (TGTX) in Q4 2025, closing a stake of 50,276 shares — an estimated $1.64M sold.

Caption Management first reported a position in TGTX in Q3 2018 and held it in 11 quarters. The position peaked at $12.2M in Q4 2021. 351 funds tracked by Wall St. Rank hold TGTX as of Q4 2025.

  • Caption Management reported no remaining TG Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 50,276 TG Therapeutics shares in Q4 2025, an estimated $1.64M.
  • Caption Management first reported a position in TG Therapeutics in Q3 2018 and held it in 11 quarters.
  • Caption Management's TG Therapeutics position peaked at $12.2M in Q4 2021.
  • 351 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.